Kevin Shao-Ang Wei, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Synovial Membrane | 13 | 2024 | 507 | 1.620 |
Why?
|
| Arthritis, Rheumatoid | 17 | 2024 | 3712 | 1.620 |
Why?
|
| Fibroblasts | 11 | 2022 | 4161 | 1.140 |
Why?
|
| Macrophage Activation Syndrome | 2 | 2023 | 111 | 0.410 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2021 | 2425 | 0.410 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2013 | 563 | 0.400 |
Why?
|
| Signal Transduction | 7 | 2021 | 23403 | 0.340 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 1114 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2013 | 3508 | 0.290 |
Why?
|
| Receptors, Growth Factor | 1 | 2007 | 334 | 0.280 |
Why?
|
| Stromal Cells | 3 | 2022 | 1355 | 0.280 |
Why?
|
| Adenoviridae | 3 | 2010 | 1099 | 0.250 |
Why?
|
| Liver | 3 | 2013 | 7474 | 0.210 |
Why?
|
| Single-Cell Analysis | 7 | 2021 | 2183 | 0.210 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 1224 | 0.210 |
Why?
|
| Insulin | 2 | 2013 | 6580 | 0.200 |
Why?
|
| Synovial Fluid | 2 | 2021 | 394 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2010 | 1676 | 0.190 |
Why?
|
| Cell Polarity | 2 | 2021 | 645 | 0.190 |
Why?
|
| Tumor Escape | 1 | 2023 | 349 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2023 | 542 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2017 | 1116 | 0.170 |
Why?
|
| Arthritis, Experimental | 1 | 2021 | 291 | 0.170 |
Why?
|
| Neutrophil Infiltration | 1 | 2021 | 390 | 0.170 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 260 | 0.170 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 93 | 0.160 |
Why?
|
| Arteriovenous Fistula | 1 | 2021 | 315 | 0.160 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 310 | 0.160 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 9438 | 0.150 |
Why?
|
| Interleukin-1 | 1 | 2021 | 1263 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2007 | 3420 | 0.150 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 15 | 0.150 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2017 | 61 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2019 | 675 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 4479 | 0.140 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10180 | 0.140 |
Why?
|
| Autocrine Communication | 1 | 2017 | 171 | 0.140 |
Why?
|
| Cadherins | 2 | 2018 | 907 | 0.140 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 986 | 0.130 |
Why?
|
| Flow Cytometry | 4 | 2019 | 5974 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 972 | 0.130 |
Why?
|
| Cryoglobulinemia | 1 | 2016 | 87 | 0.130 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 561 | 0.130 |
Why?
|
| Inflammation | 6 | 2023 | 10638 | 0.130 |
Why?
|
| Myeloblastin | 1 | 2015 | 101 | 0.130 |
Why?
|
| Systemic Vasculitis | 1 | 2015 | 37 | 0.130 |
Why?
|
| Nephritis, Interstitial | 1 | 2016 | 156 | 0.120 |
Why?
|
| Antirheumatic Agents | 1 | 2024 | 1339 | 0.120 |
Why?
|
| Sjogren's Syndrome | 1 | 2016 | 233 | 0.120 |
Why?
|
| Mice | 15 | 2022 | 81183 | 0.120 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2015 | 288 | 0.110 |
Why?
|
| Monocytes | 2 | 2019 | 2596 | 0.110 |
Why?
|
| Cell Differentiation | 5 | 2021 | 11483 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 944 | 0.110 |
Why?
|
| Chromatin | 1 | 2023 | 2934 | 0.100 |
Why?
|
| B-Lymphocytes | 3 | 2023 | 4665 | 0.100 |
Why?
|
| Peroxidase | 1 | 2015 | 611 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2133 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 2988 | 0.100 |
Why?
|
| Animals | 17 | 2022 | 168757 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2021 | 4286 | 0.090 |
Why?
|
| Humans | 34 | 2024 | 744343 | 0.090 |
Why?
|
| Endothelial Cells | 2 | 2020 | 3479 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2018 | 2133 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2019 | 1886 | 0.080 |
Why?
|
| Neutrophils | 1 | 2021 | 3719 | 0.080 |
Why?
|
| Osteogenesis | 2 | 2021 | 1299 | 0.080 |
Why?
|
| Joints | 2 | 2019 | 326 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2019 | 3461 | 0.070 |
Why?
|
| Macrophages | 2 | 2019 | 5655 | 0.070 |
Why?
|
| DNA, Recombinant | 1 | 2007 | 476 | 0.070 |
Why?
|
| Transcription Factor Brn-3A | 1 | 2006 | 12 | 0.070 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2007 | 664 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 21827 | 0.070 |
Why?
|
| Cytokines | 4 | 2023 | 7322 | 0.070 |
Why?
|
| Stem Cell Niche | 1 | 2008 | 346 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3279 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1889 | 0.060 |
Why?
|
| Cartilage | 1 | 2008 | 818 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 422 | 0.060 |
Why?
|
| Kidney | 2 | 2021 | 7186 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14557 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 4554 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2007 | 705 | 0.060 |
Why?
|
| Rheumatoid Factor | 1 | 2024 | 188 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2007 | 721 | 0.060 |
Why?
|
| Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2010 | 1660 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2018 | 13033 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2023 | 378 | 0.050 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2001 | 76 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2023 | 645 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2006 | 726 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2012 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2006 | 726 | 0.050 |
Why?
|
| Glucose | 1 | 2013 | 4397 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 225 | 0.050 |
Why?
|
| Granzymes | 1 | 2022 | 271 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2021 | 262 | 0.050 |
Why?
|
| Chromosomes | 1 | 2023 | 596 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 297 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2023 | 794 | 0.040 |
Why?
|
| RANK Ligand | 1 | 2021 | 326 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2006 | 3144 | 0.040 |
Why?
|
| Phenotype | 3 | 2023 | 16365 | 0.040 |
Why?
|
| Gelatinases | 1 | 2019 | 94 | 0.040 |
Why?
|
| Obesity | 2 | 2018 | 12745 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2022 | 4386 | 0.040 |
Why?
|
| Male | 10 | 2024 | 350118 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 1222 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 844 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12072 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 743 | 0.040 |
Why?
|
| Cell Shape | 1 | 2019 | 375 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6622 | 0.040 |
Why?
|
| Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2021 | 729 | 0.040 |
Why?
|
| STAT4 Transcription Factor | 1 | 2017 | 96 | 0.040 |
Why?
|
| Methotrexate | 1 | 2024 | 1727 | 0.040 |
Why?
|
| Chemokine CXCL13 | 1 | 2017 | 54 | 0.040 |
Why?
|
| Receptors, CXCR5 | 1 | 2017 | 92 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1880 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2017 | 424 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 193 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2021 | 1057 | 0.030 |
Why?
|
| Hematoma | 1 | 2021 | 758 | 0.030 |
Why?
|
| Cell Survival | 1 | 2006 | 5882 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2008 | 3386 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 791 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2019 | 772 | 0.030 |
Why?
|
| Ovarian Neoplasms | 2 | 2010 | 4838 | 0.030 |
Why?
|
| Antibodies | 1 | 2023 | 2460 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2017 | 389 | 0.030 |
Why?
|
| Pericytes | 1 | 2018 | 292 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 1475 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2015 | 428 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2023 | 2035 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 1072 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 2017 | 669 | 0.030 |
Why?
|
| Cell Separation | 1 | 2019 | 1751 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2018 | 670 | 0.030 |
Why?
|
| Female | 11 | 2024 | 380194 | 0.030 |
Why?
|
| Chemokines | 1 | 2018 | 970 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 577 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2001 | 2499 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2013 | 198 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6386 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 791 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2018 | 19229 | 0.020 |
Why?
|
| Rheumatic Diseases | 1 | 2018 | 592 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2019 | 1349 | 0.020 |
Why?
|
| Exanthema | 1 | 2016 | 501 | 0.020 |
Why?
|
| Mice, SCID | 2 | 2006 | 2716 | 0.020 |
Why?
|
| Leukocytes | 1 | 2019 | 2043 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 1838 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1620 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2022 | 3589 | 0.020 |
Why?
|
| Genome, Human | 1 | 2023 | 4420 | 0.020 |
Why?
|
| Adipocytes | 1 | 2017 | 1184 | 0.020 |
Why?
|
| Child | 3 | 2023 | 77709 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 9734 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 11725 | 0.020 |
Why?
|
| Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
| Middle Aged | 5 | 2024 | 213383 | 0.020 |
Why?
|
| Fatigue | 1 | 2016 | 1531 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2019 | 2575 | 0.020 |
Why?
|
| Base Sequence | 1 | 2019 | 12797 | 0.020 |
Why?
|
| Dyspnea | 1 | 2016 | 1303 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2023 | 12208 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1632 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3200 | 0.020 |
Why?
|
| Choristoma | 1 | 2008 | 213 | 0.020 |
Why?
|
| Chemokine CXCL11 | 1 | 2006 | 42 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 2104 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3521 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3597 | 0.020 |
Why?
|
| Receptors, CXCR | 1 | 2006 | 52 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7799 | 0.020 |
Why?
|
| Time Factors | 1 | 2007 | 40075 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3023 | 0.020 |
Why?
|
| Adult | 4 | 2022 | 214055 | 0.020 |
Why?
|
| Polycythemia | 1 | 2006 | 126 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 2307 | 0.020 |
Why?
|
| Hematocrit | 1 | 2006 | 636 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5217 | 0.020 |
Why?
|
| Radiography | 1 | 2016 | 7023 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2006 | 464 | 0.020 |
Why?
|
| Skull | 1 | 2008 | 813 | 0.010 |
Why?
|
| Mandible | 1 | 2008 | 740 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3864 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3557 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 627 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7880 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 17446 | 0.010 |
Why?
|
| Genomics | 1 | 2018 | 5720 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3505 | 0.010 |
Why?
|
| Fetus | 1 | 2008 | 1880 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 2006 | 772 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 56430 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12959 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2001 | 252 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 4851 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 2171 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 35136 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 2001 | 486 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 41006 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25043 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4026 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 21683 | 0.010 |
Why?
|
| Lung | 1 | 2016 | 9856 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 163280 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 3701 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3617 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9386 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16689 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6314 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 5892 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85781 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 2503 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15997 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 8436 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 57776 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18029 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2015 | 77449 | 0.000 |
Why?
|
| Pregnancy | 1 | 2006 | 29144 | 0.000 |
Why?
|